ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

CRSP CRISPR Therapeutics AG

54.87
1.06 (1.97%)
최종 업데이트: 04:14:13
15분 지연
기업명 주식 심볼 시장 주식 타입
CRISPR Therapeutics AG CRSP 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
1.06 1.97% 54.87 04:14:13
개장가 저가 고가 종가 전일 종가
54.48 53.985 55.34 53.81
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
23/04/202405:30GLOBECRISPR Therapeutics to Present Oral Presentation at the..
03/04/202421:00GLOBECRISPR Therapeutics to Present at the Annual Needham Virtual..
01/04/202421:00GLOBECRISPR Therapeutics to Present at the American Society of..
13/03/202421:30GLOBECRISPR Therapeutics Proposes New Appointment to the Board of..
22/02/202407:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/02/202407:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/02/202421:50EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
21/02/202421:45EDGAR2Form 8-K - Current report
21/02/202421:30GLOBECRISPR Therapeutics Provides Business Update and Reports..
17/02/202407:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/02/202406:30EDGAR2Form 144 - Report of proposed sale of securities
15/02/202422:30GLOBECRISPR Therapeutics to Present at the Citi 2024 Virtual..
13/02/202422:44EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
13/02/202422:30GLOBECRISPR Therapeutics Announces $280 Million Registered Direct..
13/02/202420:30EDGAR2Form 8-K - Current report
13/02/202416:30GLOBEEuropean Commission Approves First CRISPR/Cas9 Gene-Edited..
01/02/202407:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/01/202406:08EDGAR2Form 144 - Report of proposed sale of securities
30/01/202406:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
19/01/202407:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/01/202407:00EDGAR2Form 144 - Report of proposed sale of securities
17/01/202406:11EDGAR2Form 8-K - Current report
17/01/202406:01GLOBECRISPR Therapeutics Announces U.S. Food and Drug..
11/01/202401:36EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/01/202421:00GLOBECRISPR Therapeutics Highlights Strategic Priorities and 2024..
03/01/202422:30GLOBECRISPR Therapeutics to Present at the 42nd Annual J.P...
20/12/202306:23EDGAR2Form 8-K - Current report
15/12/202322:58EDGAR2Form 8-K - Current report
13/12/202323:22EDGAR2Form 8-K - Current report
09/12/202306:11DJNBluebird Bio Shares Slide 41% on Black-Box Label, Higher..
09/12/202303:16EDGAR2Form 8-K - Current report
09/12/202302:52BWVertex and CRISPR Therapeutics Announce US FDA Approval of..
09/12/202301:46DJNCRISPR, Vertex Get FDA OK of Casgevy Gene Therapy in..
05/12/202306:26EDGAR2Form 8-K - Current report
05/12/202306:15GLOBECRISPR Therapeutics Announces Updates to Immuno-Oncology..
16/11/202321:21EDGAR2Form 8-K - Current report
16/11/202315:45BW Vertex and CRISPR Therapeutics Announce Authorization of..
07/11/202306:42EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202306:33EDGAR2Form 8-K - Current report
07/11/202306:15GLOBECRISPR Therapeutics Provides Business Update and Reports..
06/11/202319:01GLOBECRISPR Therapeutics Announces Preclinical Data at the..
01/11/202319:29DJNCrispr Therapeutics Shares Rally Premarket After Favorable..
01/11/202306:53GLOBECRISPR Therapeutics Announces Completion of FDA Advisory..
31/10/202320:05GLOBECRISPR Therapeutics Trading Halted Today; FDA Advisory..
18/10/202306:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/10/202306:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/10/202306:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/10/202306:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/10/202321:00GLOBECRISPR Therapeutics Proposes New Appointment to the Board of..
27/09/202322:01GLOBECRISPR Therapeutics to Present at the Society for..

최근 히스토리

Delayed Upgrade Clock